About MARAbio
MARAbio is a company based in Salt Lake City (United States) founded in 2016 by Judy Van De Water and Michael S Paul.. MARAbio has raised $19.06 million across 1 funding round from investors including MAK Capital. MARAbio offers products and services including MARA Blood Test. MARAbio operates in a competitive market with competitors including Lineagen, Linus Biotechnology, Pediatric Bioscience, SensOmics and NeuroPoint Dx, among others.
- Headquarter Salt Lake City, United States
- Founders Judy Van De Water, Michael S Paul
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$19.06 M (USD)
in 1 rounds
-
Latest Funding Round
$19.06 M (USD), Series A
Sep 16, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MARAbio
MARAbio offers a comprehensive portfolio of products and services, including MARA Blood Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Blood test to detect antibodies predicting autism risk in children.
Unlock access to complete
Unlock access to complete
Funding Insights of MARAbio
MARAbio has successfully raised a total of $19.06M through 1 strategic funding round. The most recent funding activity was a Series A round of $19.06 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $19.1M
-
First Round
First Round
(16 Sep 2024)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series A - MARAbio | Valuation | MAK Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MARAbio
MARAbio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MAK Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MARAbio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MARAbio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Marabio Comparisons
Competitors of MARAbio
MARAbio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lineagen, Linus Biotechnology, Pediatric Bioscience, SensOmics and NeuroPoint Dx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sequencing-based diagnostic tests and services for autism are provided.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic tests for central nervous system and gastrointestinal disorders
|
|
| domain | founded_year | HQ Location |
Provides blood biomarker-based diagnostics for autism spectrum disorders.
|
|
| domain | founded_year | HQ Location |
Precision medicine for children's health is provided through genomic integration.
|
|
| domain | founded_year | HQ Location |
Metabolomics for neuro-developmental disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Marabio
Frequently Asked Questions about MARAbio
When was MARAbio founded?
MARAbio was founded in 2016 and raised its 1st funding round 8 years after it was founded.
Where is MARAbio located?
MARAbio is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Who is the current CEO of MARAbio?
Michael S Paul is the current CEO of MARAbio. They have also founded this company.
Is MARAbio a funded company?
MARAbio is a funded company, having raised a total of $19.06M across 1 funding round to date. The company's 1st funding round was a Series A of $19.06M, raised on Sep 16, 2024.
What does MARAbio do?
MARAbio was founded in 2016 in Salt Lake City, United States, within the biotechnology sector focused on diagnostic tools. Precision blood tests are developed to identify specific autoantibodies in women, which are linked to autism development in children. Operations center on early risk assessment through this technology, supporting maternal health evaluations in clinical settings across the U.S.
Who are the top competitors of MARAbio?
MARAbio's top competitors include Linus Biotechnology, Lineagen and FBB Biomed.
What products or services does MARAbio offer?
MARAbio offers MARA Blood Test.
Who are MARAbio's investors?
MARAbio has 1 investor. Key investors include MAK Capital.